Today: 12 June 2026
Browse Category

NASDAQ:ARTV 17 October 2025 - 16 December 2025

Artiva Biotherapeutics (ARTV) Stock: Today’s News (Dec. 16, 2025), Why Shares Spiked, Analyst Forecasts, and What Investors Are Watching Next

Artiva Biotherapeutics (ARTV) Stock: Today’s News (Dec. 16, 2025), Why Shares Spiked, Analyst Forecasts, and What Investors Are Watching Next

Artiva Biotherapeutics shares surged to around $6.30 on December 16 after trading between $4.08 and $7.25 in a session with volume near 48 million shares. CEO Fred Aslan disclosed selling 3,187 shares at $6.00 each on December 15 under a pre-arranged plan, according to an SEC Form 4. The company’s market cap stands near $155 million.
16 December 2025
Artiva Biotherapeutics (ARTV) Stock Skyrockets on FDA Fast Track News – What’s Next for Investors?

Artiva Biotherapeutics (ARTV) Stock Skyrockets on FDA Fast Track News – What’s Next for Investors?

Artiva Biotherapeutics shares surged nearly 100% in after-hours trading Oct. 16 after the FDA granted Fast Track status to its AlloNK cell therapy for refractory rheumatoid arthritis. The stock jumped from a $2.77 close to as high as $6.33. Over 20 patients have received AlloNK in trials, with key safety and mechanistic data expected by mid-November. Artiva plans to begin a pivotal Phase 3 trial in 2026, pending results.
17 October 2025
·

Stock Market Today

  • RH Reports Q1 Loss, Exceeds Revenue Estimates Despite Earnings Miss
    June 11, 2026, 7:09 PM EDT. RH reported a quarterly loss of $0.40 per share, missing the expected loss of $0.08, contrasting with earnings of $2.21 per share a year ago. Revenue for Q1 reached $727 million, slightly above estimates, but down from last year. The furniture and housewares company's earnings have only topped estimates once in the past year. Shares have fallen 2% year-to-date, underperforming the S&P 500, which gained 13.7%. RH holds a Zacks Rank #4 (Sell), reflecting unfavorable earnings estimate revisions. The current fiscal outlook projects $3.74 EPS on $864 million revenue next quarter and $8.91 EPS on $3.24 billion revenue for the year. Industry trends in Consumer Products - Staples remain positive but cautious.

Latest articles

SpaceX IPO Talk Sends Firefly Aerospace Shares Up 18%

SpaceX IPO Talk Sends Firefly Aerospace Shares Up 18%

12 June 2026
Firefly Aerospace shares jumped 17.8% to $39.37 as SpaceX’s record $75 billion IPO fueled investor interest in space stocks, though Firefly remains below its recent $48 offering price, keeping dilution and valuation in focus.
AST SpaceMobile Jumps After BlueBird Launch Date News

AST SpaceMobile Jumps After BlueBird Launch Date News

12 June 2026
AST SpaceMobile shares soared 11.73% to $97.56 after confirming BlueBird satellites 8, 9, and 10 will launch June 17 on a Falcon 9, aiming to nearly double peak data speeds for its direct-to-smartphone broadband network; shares reached $101.00 after hours as investors focused on this key deployment milestone following recent volatility.
Sandisk Jumps to 52-Week High, Gains 14.5% in AI-Fueled Push

Sandisk Jumps to 52-Week High, Gains 14.5% in AI-Fueled Push

12 June 2026
Sandisk soared 14.5% to $1,881.51 after hitting a 52-week high amid a semiconductor rally, fueled by a 251% year-over-year revenue jump and bullish guidance for Q4 revenue of $7.75–$8.25 billion; Bank of America raised its price target to $2,100, citing strong memory pricing and supply contracts, as Sandisk joins the Nasdaq-100 and investors eye data-center demand and new business agreements.
Go toTop